No abstract available
MeSH terms
-
Adult
-
Antineoplastic Agents / therapeutic use*
-
Benzamides
-
Blast Crisis / drug therapy*
-
Female
-
Fusion Proteins, bcr-abl / genetics
-
Humans
-
Imatinib Mesylate
-
In Situ Hybridization, Fluorescence
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Oncogene Proteins, Fusion / genetics*
-
Piperazines / therapeutic use*
-
Polymerase Chain Reaction
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / genetics*
-
Pyrimidines / therapeutic use*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Oncogene Proteins, Fusion
-
Piperazines
-
Pyrimidines
-
TEL-ABL fusion protein, human
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases
-
Fusion Proteins, bcr-abl